Objective Markers of Pain Perception in Humans
2 other identifiers
interventional
21
1 country
2
Brief Summary
Determine objective markers of pain perception remains a major scientific and medical issue. Various tools have been proposed to objectify pain, but their adaptability to different clinical contexts are limited. Our working hypothesis considers that the research for markers of immediate pain perception should be based on an electrophysiological approach, based on the combined analysis of EEG and autonomic responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Jun 2014
Longer than P75 for not_applicable healthy
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 4, 2014
CompletedFirst Submitted
Initial submission to the registry
September 24, 2015
CompletedFirst Posted
Study publicly available on registry
September 25, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2018
CompletedOctober 23, 2018
October 1, 2018
3.7 years
September 24, 2015
October 22, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EEG Gamma power.
The EGG signals are compared between a painful stimuli tonic to those evoked by non-painful stimuli.
Baseline
Secondary Outcomes (3)
ratio of low to high frequency spectral powers
Baseline
Magnitude of the sympathetic cutaneous reactivity
Baseline
Amplitude of pupillary dilation
Baseline
Study Arms (1)
EEG responses
OTHERThe study compares electroencephalographical responses (EEG) to painful stimuli tonic to those evoked by non-painful stimuli and with or without virtual reality
Interventions
Eligibility Criteria
You may qualify if:
- Affiliate or beneficiary of social security
- Signature of consent
You may not qualify if:
- History of cardiovascular disease (vagal syncope, hypertension, etc ...), renal, metabolic (diabetes ...), psychiatric (depression, etc ...) or neurological (seizure, etc ...) syndromes;
- Reynaud's syndrome;
- Raynaud's disease;
- Acrocyanosis;
- Known rhythm disorders;
- Participation at the same time in another clinical trial;
- Taking a medical treatment;
- Suffering from acute (complaint of pain in the week before the test) or chronic pain,
- Allergic to conductive gel for electrodes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hospices Civils de LYON
Lyon, 69500, France
CHU de SAINT-ETIENNE
Saint-Etienne, 42000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roland PEYRON, MD
CHU de SAINT-ETIENNE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2015
First Posted
September 25, 2015
Study Start
June 4, 2014
Primary Completion
February 28, 2018
Study Completion
February 28, 2018
Last Updated
October 23, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share